non glp-1 weight loss drugs π¨ DRUGS: A BREAKTHROUGH OR A NEW RISK? π€π, π₯ βThe Hidden Side of GLP-1s: Could Weight Loss Trigger Eating Disorders?β π₯, GLP-1 medications such as semaglutide and tirzepatide GLP-1 medications for weight loss
Description
Common Misconceptions About GLP-1 Medications It is just an appetite suppressant. Not really

Overall, our meta-analysis underscores the value of GLP-1RAs as a multifaceted therapeutic option, particularly in PCOS patients with obesity and IR

some randomized controlled trials demonstrated that liraglutide, dulaglutide, semaglutide, and albiglutide reduced the rate of CV events in T2DM patients ( Another novel glucose-lowering agent is tirzepatide which has a dual mechanism of action: a GLP-1 and a glucose-dependent insulinotropic polypeptide (GIP) co-agonist

[DOI] [PMC free article] [PubMed] [Google Scholar] 579.Hvidberg A., Nielsen M.T., Hilsted J., Orskov C., Holst J.J

Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al
doi: 10.1053/j.gastro.2007.03.054 [DOI] [PubMed] [Google Scholar] 82.Seufert J, Gallwitz B
